Philips Respironics Trilogy EV300 Recalled 113,717 Units Worldwide for Tidal Volume Discrepancy (202
Philips Respironics recalled 113,717 Trilogy EV300 ventilators sold worldwide through healthcare distributors on March 2, 2026. Using non-pneumatic nebulizers with Trilogy Evo Platform ventilators may cause a mismatch between the set tidal volume and the delivered tidal volume. Patients and healthcare providers should stop using the device immediately and follow the recall instructions from the 제조
Quick Facts at a Glance
Recall Date
March 2, 2026
Hazard Level
HIGH
Brand
Philips Respironics
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL
Hazard Information
Using non-pneumatic nebulizers with Trilogy Evo Platform ventilators may result in a discrepancy between the set tidal volume and the tidal volume received by the patient.
What You Should Do
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Philips Respironics, Inc. or your healthcare provider for instructions. Notification method: Letter
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
No spamUnsubscribe anytime
About This Product
The Trilogy EV300 is a continuous home-use ventilator intended to support patients with respiratory failure. It is used under medical supervision, often in home settings or during non-acute care.
Why This Is Dangerous
Using non-pneumatic nebulizers with the Trilogy Evo Platform can cause a mismatch between the set and delivered tidal volumes, potentially compromising ventilation and patient safety.
Industry Context
This recall is not described as part of a broader industry pattern in the notice.
Real-World Impact
Hospitals and home-care patients may face interruptions in supply or require urgent device replacements, creating safety and care continuity concerns.
Practical Guidance
How to identify if yours is affected
Verify device is Trilogy EV300.
Check software version 1.05.15.00 on the device label or system menu.
Confirm use of non-pneumatic nebulizers with the Evo Platform.
Where to find product info
Recall notices available via FDA enforcement page and Philips Respironics recall communications to healthcare providers.
What timeline to expect
Remedy timelines are not specified in the recall notice.
If the manufacturer is unresponsive
Escalate to regulatory authorities (FDA) if the manufacturer is slow to respond.
Document all communications and keep the recall letter or notice.
How to prevent similar issues
Use only compatible nebulizers specified by Philips.
Consult healthcare providers before changing nebulizer equipment.
Monitor patient ventilation and report any unusual symptoms immediately.
Documentation advice
Keep recall letter, model numbers, software version, dates of service, and all correspondence with Philips or healthcare providers.
Product Details
Model numbers: All Model No., All UDI, All Serial No.
Where sold: Worldwide distribution through healthcare distributors
When sold: Unknown
Price: Unknown (price range not disclosed)
Philips Respironics recalled 113,717 Trilogy Evo ventilators worldwide on March 2, 2026. The recall concerns software Version 1.05.15.00 and the use of non-pneumatic nebulizers with the Trilogy Evo platform. Hospitals and patients should stop using the device immediately and follow recall instructions from Philips Respironics or their healthcare provider.
Philips Respironics recalled 113,717 Trilogy Evo Universal ventilators worldwide on March 2, 2026. The recall cites a condition where using non-pneumatic nebulizers may cause a discrepancy between the set tidal volume and the delivered tidal volume. Patients and caregivers should stop using the device immediately and contact Philips Respironics or their healthcare provider for instructions.
Philips Respironics recalled 113,717 Trilogy Evo O2 home-use ventilators worldwide on March 2, 2026 after determining that using non-pneumatic nebulizers with the device can cause a mismatch between the set tidal volume and the delivered tidal volume. The defect could lead to under- or over-ventilation with serious health consequences. Stop using the device immediately and follow the recall steps.
Philips Respironics recalls 113,717 Trilogy Evo O2 home-use ventilators in 2026. The Obstruction Alarm may fail to trigger within required standards, delaying warning for airway obstruction for up to four breaths. Stop using the device and follow recall instructions from Philips or your clinician.
Philips Respironics recalled 113,717 Trilogy Evo home-use ventilators worldwide after finding the Obstruction Alarm may fail to trigger, potentially delaying alerts by up to four breaths. The devices were distributed nationwide in the United States and internationally. Consumers should stop using the device immediately and follow the manufacturer’s recall instructions.
Philips Respironics recalled 113,717 Trilogy Evo Universal home-use ventilators sold by multiple retailers after alarms may fail to trigger. The obstruction alarm may not trigger within the required timeframe, delaying warning by up to four breaths. Patients should stop using the device and follow the manufacturer’s recall instructions or contact their healthcare provider for guidance.
Philips Respironics recalled 113,717 Trilogy EV300 ventilators sold in the United States and internationally after determining the Obstruction Alarm may fail to trigger within required standards. The alarm can delay alerting caregivers for up to four breaths. Patients and healthcare providers should stop using the device immediately and follow recall instructions from Philips or their clinician.